These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 33746597)

  • 21. Role of SIRT1 in regulation of epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis.
    Chen IC; Chiang WF; Huang HH; Chen PF; Shen YY; Chiang HC
    Mol Cancer; 2014 Nov; 13():254. PubMed ID: 25424420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. microRNA-203 suppresses invasion of gastric cancer cells by targeting ERK1/2/Slug/ E-cadherin signaling.
    Gao P; Wang S; Jing F; Zhan J; Wang Y
    Cancer Biomark; 2017; 19(1):11-20. PubMed ID: 28269747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-204 regulates the EMT by targeting snai1 to suppress the invasion and migration of gastric cancer.
    Liu Z; Long J; Du R; Ge C; Guo K; Xu Y
    Tumour Biol; 2016 Jun; 37(6):8327-35. PubMed ID: 26729198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-96-5p regulated TGF-β/SMAD signaling pathway and suppressed endometrial cell viability and migration via targeting TGFBR1.
    Chen S; Luo Y; Cui L; Yang Q
    Cell Cycle; 2020 Jul; 19(14):1740-1753. PubMed ID: 32635855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The transcription factor c-Jun regulates Smad4 expression by upregulating pre-miR-183 expression to promote invasion and metastasis of esophageal squamous cell carcinomas.
    Xu X; Zheng L; Hang N; Zhu G; Mao W; Fan Y; Tao K
    In Vitro Cell Dev Biol Anim; 2020 Aug; 56(7):550-558. PubMed ID: 32886291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-520c-3p negatively regulates EMT by targeting IL-8 to suppress the invasion and migration of breast cancer.
    Tang CP; Zhou HJ; Qin J; Luo Y; Zhang T
    Oncol Rep; 2017 Nov; 38(5):3144-3152. PubMed ID: 29048659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Smad4-dependent TGF-beta signaling suppresses RON receptor tyrosine kinase-dependent motility and invasion of pancreatic cancer cells.
    Zhao S; Ammanamanchi S; Brattain M; Cao L; Thangasamy A; Wang J; Freeman JW
    J Biol Chem; 2008 Apr; 283(17):11293-301. PubMed ID: 18310076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-564 is downregulated in glioblastoma and inhibited proliferation and invasion of glioblastoma cells by targeting TGF-β1.
    Jiang C; Shen F; Du J; Hu Z; Li X; Su J; Wang X; Huang X
    Oncotarget; 2016 Aug; 7(35):56200-56208. PubMed ID: 27621042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circ-GGA3 promotes the biological functions of human lens epithelial cells depending on the regulation of miR-497-5p/SMAD4 axis.
    Wang H; Zheng G
    Biochem Biophys Res Commun; 2022 Apr; 598():62-68. PubMed ID: 35151205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/β-catenin signaling pathway by down-regulating LHX2.
    Liang TS; Zheng YJ; Wang J; Zhao JY; Yang DK; Liu ZS
    J Exp Clin Cancer Res; 2019 Feb; 38(1):97. PubMed ID: 30791932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MIR-27a regulates the TGF-β signaling pathway by targeting SMAD2 and SMAD4 in lung cancer.
    Chae DK; Ban E; Yoo YS; Kim EE; Baik JH; Song EJ
    Mol Carcinog; 2017 Aug; 56(8):1992-1998. PubMed ID: 28370334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. microRNA-145 modulates epithelial-mesenchymal transition and suppresses proliferation, migration and invasion by targeting SIP1 in human cervical cancer cells.
    Sathyanarayanan A; Chandrasekaran KS; Karunagaran D
    Cell Oncol (Dordr); 2017 Apr; 40(2):119-131. PubMed ID: 27933466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-126-3p suppresses the growth, migration and invasion of NSCLC via targeting CCR1.
    Liu R; Zhang YS; Zhang S; Cheng ZM; Yu JL; Zhou S; Song J
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):679-689. PubMed ID: 30720175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-20a-5p promotes colorectal cancer invasion and metastasis by downregulating Smad4.
    Cheng D; Zhao S; Tang H; Zhang D; Sun H; Yu F; Jiang W; Yue B; Wang J; Zhang M; Yu Y; Liu X; Sun X; Zhou Z; Qin X; Zhang X; Yan D; Wen Y; Peng Z
    Oncotarget; 2016 Jul; 7(29):45199-45213. PubMed ID: 27286257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 37. MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing SMAD4 in thyroid cancer.
    Geraldo MV; Yamashita AS; Kimura ET
    Oncogene; 2012 Apr; 31(15):1910-22. PubMed ID: 21874046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer.
    Yu J; Xie F; Bao X; Chen W; Xu Q
    Mol Cancer; 2014 May; 13():121. PubMed ID: 24885626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hsa-miR-5582-3P regulatory effect on TGFβ signaling through targeting of TGFβ-R1, TGFβ-R2, SMAD3, and SMAD4 transcripts.
    Abedini Bakhshmand E; Mohammad Soltani B; Fasihi A; Mowla SJ
    J Cell Biochem; 2018 Dec; 119(12):9921-9930. PubMed ID: 30129155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-381 inhibits the metastasis of gastric cancer by targeting TMEM16A expression.
    Cao Q; Liu F; Ji K; Liu N; He Y; Zhang W; Wang L
    J Exp Clin Cancer Res; 2017 Feb; 36(1):29. PubMed ID: 28193228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.